Ignite Creation Date:
2024-05-06 @ 2:45 PM
Last Modification Date:
2024-10-26 @ 1:36 PM
Study NCT ID:
NCT04415008
Status:
RECRUITING
Last Update Posted:
2023-10-05
First Post:
2020-05-31
Brief Title:
Efficacy of HAD Induction With Intensified Cytarabine in Newly-diagnosed CEBPA Double Mutated Acute Myeloid Leukemia
Sponsor:
wang jianxiang
Organization:
Institute of Hematology Blood Diseases Hospital China
Organization Data
Organization:
Institute of Hematology Blood Diseases Hospital China
Class:
OTHER
Study ID:
IHBD-IIT2020008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
wang jianxiang
Lead Sponsor Class:
OTHER
Responsible Party:
wang jianxiang
Responsible Party Title:
Director of leukemia center
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Institute of Hematology Blood Diseases Hospital China
Old Name:
None
Old Organization:
None